Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: Potential use for initial therapy of freshly diagnosed tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 6, 1996, Pages 1049-1053

  Amaral, L ^a   Kristiansen, J E ^b,c   Abebe, L S ^a,d   Millett, W ^a  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

^b HILLERØD HOSPITAL   (Denmark)

^c Sonderborg Hospital   (Denmark)

^d New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIORIDAZINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ANTIPSYCHOTIC AGENTS; ANTITUBERCULAR AGENTS; CHLORPROMAZINE; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; KINETICS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXYGEN CONSUMPTION; THIORIDAZINE; TUBERCULOSIS;

EID: 0030462751     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.6.1049     Document Type: Article

References (10)

1. Bourdon, J. L. (1961). Contribution a l'etude des proprietes antibiotiques de la chlorpromazine ou 4560 RP. Annales de I'Institute Pasteur 101, 876-86.
2. Crowle, A. J., Douvas, G. S. & May, M. H. (1992). Chlorpromazine: a drug potentially useful for treating mycobacterial infections. Chemotherapy 38, 410-9.
3. Fisher, R. A. & Teller, E. (1959). Clinical experience with ataractic therapy in tuberculous psychiatric patients. Diseases of the Chest 34, 134-9.
4. Forrest, F. M., Forrest, I. S. & Roizin, L. E. (1963). Clinical, biochemical and post-mortem studies on a patient treated with chlorpromazine. Revue Agressologie 4, 259-64.
5. Hyttel, J., Larsen, J.-J., Christensen, A. V. & Amt, J. (1984). Receptor binding profiles of neuroleptics. In "Dyskinesia" Research and Treatment. Psychopharmacology Supplement 2 (Casey, D. E., Chase, T. N., Christensen, A. V. & Gerlach, J., Eds), pp. 9 18. Springer-Verlag, Berlin.
6. Interlied, C. B. (1991). Antimyrobacterial agents: in vitro susceptibility testing spectrum of activity, mechanisms of action and resistance, and assays for activity in biological fluids. In Antibiotics in Laboratory Medicine, 2nd edn (Lorian, V. L., Ed.), pp. 134-97. Williams & Wilkins, Baltimore, MD.
7. Kristiansen, J. E. & Vergmann, B. (1986). The anti-bacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria. Acta Pathology Microbiology Immunology Scandinavia Section B, 94, 393-8.
8. Molnár, J., Beladi, I. & Földes, I. (1977). Studies on antituberculotic action of some phenothiazine derivatives in vitro. Zentralhlatt für Bakteriologie, Mikrobiologie und Hygiene I. Abterilung Originale A 239, 521-6.
9. Anonymous. (1991). Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. Morbidity and Mortality Weekly Report 40, 585-91.
10. Williams, J. D. (1995). Selective toxicity and concordant pharmacodynamics of antibiotics and other drugs. Journal of Antimicrobial Chemotherapy 35, 721-37.